Skip to main content
SpringerLink
Log in

Monitoring Tools for Polymyalgia Rheumatica/Giant Cell Arteritis

  • Chapter
  • First Online:
Polymyalgia Rheumatica and Giant Cell Arteritis

  • 642 Accesses

Abstract

Usually, polymyalgia rheumatica shows a rapid onset with severe and symmetric muscle pain in the shoulder girdle and the neck, less often in the pelvic girdle, accompanied by muscle tenderness. Patients suffer from continuous pain, often aggravated during physical inactivity or the night. Sometimes transient synovitis occurs without radiological signs of arthritis (see Table 13.1) [1]. Approximately, two thirds of patients with giant cell arteritis have new-onset headache. This headache is often present daily and is quite bothersome. The headache may be generalized, but it is more commonly unilateral and localized to the temporal area. When headache is absent or mild, the index of suspicion for the disorder is frequently low, and the diagnosis may be delayed for weeks or even months [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bird HA, Esselinckx W, Dixon AS, et al. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis. 1979;38:434–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Wilke WS, Wizened A, Krall PL, et al. Masked presentation of giant-cell arteritis. Cleve Clin Q. 1985;52(2):155–9.

    Article  CAS  PubMed  Google Scholar 

  3. Hunder GG. Giant cell arteritis and polymyalgia rheumatica. Med Clin North Am. 1997;81:195–219.

    Article  CAS  PubMed  Google Scholar 

  4. Bird HA, Leeb BF, Montecucco CM, et al. A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica. Ann Rheum Dis. 2005;64(4):626–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122–8.

    Article  CAS  PubMed  Google Scholar 

  6. Leeb BF, Bird HA, Nesher G, et al. EULAR response criteria for polymyalgia rheumatica. Results of an initiative of the European collaborating polymyalgia rheumatica group (subcommittee of ESCISIT [EULAR Standing Committee on Clinical Trials including Therapeutical Trials]). Ann Rheum Dis. 2003;62:1189–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Nothnagl T, Leeb BF. Diagnosis, differential diagnosis and treatment of polymyalgia rheumatica. Drugs Aging. 2006;23(5):391–402.

    Article  PubMed  Google Scholar 

  8. Weigand S, Ehrenstein B, Fleck M, Hartung W. Joint involvement in patients with early polymyalgia rheumatica using high-resolution ultrasound and its contribution to the EULAR/ACR 2012 classification criteria for polymyalgia rheumatica. J Rheumatol. 2014;41(4):730–4. doi:10.3899/jrheum.130946. Epub 2014 Mar 1.

    Article  PubMed  Google Scholar 

  9. Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C, Bachta A, Dejaco C, Duftner C, Jensen HS, Duhaut P, Poór G, Kaposi NP, Mandl P, Balint PV, Schmidt Z, Iagnocco A, Nannini C, Cantini F, Macchioni P, Pipitone N, Amo MD, Espígol-Frigolé G, Cid MC, Martínez-Taboada VM, Nordborg E, Direskeneli H, Aydin SZ, Ahmed K, Hazleman B, Silverman B, Pease C, Wakefield RJ, Luqmani R, Abril A, Michet CJ, Marcus R, Gonter NJ, Maz M, Carter RE, Crowson CS, Matteson EL. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2012;71(4):484–92. doi:10.1136/annrheumdis-2011-200329.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Ozen G, Inanc N, Unal AU, Bas S, Kimyon G, Kisacik B, Onat AM, Murat S, Keskin H, Can M, Mengi A, Cakir N, Balkarli A, Cobankara V, Yilmaz N, Yazici A, Dogru A, Sahin M, Sahin A, Gok K, Senel S, Pamuk ON, Yilmaz S, Bayindir O, Aksu K, Cagatay Y, Akyol L, Sayarlioglu M, Yildirim-Cetin G, Yasar-Bilge S, Yagci I, Aydin SZ, Alibaz-Oner F, Atagunduz P, Direskeneli H. Assessment of the new 2012 EULAR/ACR clinical classification criteria for polymyalgia rheumatica: A prospective multicenter study. J Rheumatol. 2016;43(5):893–900. doi:10.3899/jrheum.151103. Epub 2016 Feb 1.

    Article  PubMed  Google Scholar 

  11. Macchioni P, Boiardi L, Catanoso M, Pazzola G, Salvarani C. Performance of the new 2012 EULAR/ACR classification criteria for polymyalgia rheumatica: comparison with the previous criteria in a single-centre study. Ann Rheum Dis. 2014;73(6):1190–3. doi:10.1136/annrheumdis-2013-204167. Epub 2013 Dec 2.

    Article  PubMed  Google Scholar 

  12. Ninan J, Lester S, Hill C. Giant cell arteritis. Best Pract Res Clin Rheumatol. 2016;30(1):169–88. doi:10.1016/j.berh.2016.05.001. Epub 2016 Jun 20.

    Article  PubMed  Google Scholar 

  13. Jones JG, Hazleman BL. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis. 1981;40:1–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Dejaco C, Singh YP, Perel P, Hutchings A, Camellino D, Mackie S, Abril A, Bachta A, Balint P, Barraclough K, Bianconi L, Buttgereit F, Carsons S, Ching D, Cid M, Cimmino M, Diamantopoulos A, Docken W, Duftner C, Fashanu B, Gilbert K, Hildreth P, Hollywood J, Jayne D, Lima M, Maharaj A, Mallen C, Martinez-Taboada V, Maz M, Merry S, Miller J, Mori S, Neill L, Nordborg E, Nott J, Padbury H, Pease C, Salvarani C, Schirmer M, Schmidt W, Spiera R, Tronnier D, Wagner A, Whitlock M, Matteson EL, Dasgupta B, European League Against Rheumatism, American College of Rheumatology. 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheumatol. 2015;67(10):2569–80. doi:10.1002/art.39333.

    Article  PubMed  Google Scholar 

  15. Dasgupta B, Borg FA, Hassan N, et al. BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology. 2010;49:186–90. doi:10.1093/rheumatology/kep303a.

    Article  PubMed  Google Scholar 

  16. Leeb BF, Bird HA. A disease activity score for polymyalgia rheumatica—PMR-AS. Ann Rheum Dis. 2004;63:1279–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Salvarani C, Cantini F, Boiardi L, et al. Polymyalgia rheumatica and giant cell arteritis. N Engl J Med. 2002;347:261–71.

    Article  PubMed  Google Scholar 

  18. Leeb BF, Rintelen B, Sautner J, Fassl C, Bird HA. The Polymyalgia Rheumatica Activity Score (PMR-AS) in daily use—proposal for a definition of remission. Arthritis Rheum. 2007;57(5):810–5.

    Article  PubMed  Google Scholar 

  19. Binard A, Lefebvre B, De Bandt M, Berthelot JM, Saraux A, Club “Rhumatismes et Inflammation”. Validity of the Polymyalgia Rheumatica Activity Score in primary care practice. Ann Rheum Dis. 2009;68(4):541–5. Epub 2008 May 13.

    Article  CAS  PubMed  Google Scholar 

  20. Binard A, de Bandt M, Berthelot JM, Saraux A, Inflammatory Joint Disease Working Group of the French Society for Rheumatology. Performance of the polymyalgia rheumatica activity score for diagnosing disease flares. Arthritis Rheum. 2008;59(2):263–9.

    Article  PubMed  Google Scholar 

  21. Devauchelle-Pensec V, Berthelot JM, Cornec D, Renaudineau Y, Marhadour T, Jousse-Joulin S, Querellou S, Garrigues F, De Bandt M, Gouillou M, Saraux A. Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study. Ann Rheum Dis. 2016;75(8):1506–10. doi:10.1136/annrheumdis-2015-208742.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Buttgereit F, Dejaco C, Matteson EL. Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA. 2016;315(22):2442–58. doi:10.1001/jama.2016.5444.

    Article  CAS  PubMed  Google Scholar 

  23. Restuccia G, Boiardi L, Cavazza A, Catanoso M, Macchioni P, Muratore F, Soriano A, Cimino L, Aldigeri R, Crescentini F, Pipitone N, Salvarani C. Long-term remission in biopsy proven giant cell arteritis: a retrospective cohort study. J Autoimmun. 2017;77:39–44. doi:10.1016/j.jaut.2016.10.002. [Epub ahead of print].

    Article  PubMed  Google Scholar 

  24. Evans J, Steel L, Borg F, Dasgupta B. Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis. RMD Open. 2016;2(1):e000137. doi:10.1136/rmdopen-2015-000137.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Rintelen B, Bobacz K, Höfle G, Peichl P, Rainer F, Weber K, Gaugg M, Arbeitsgruppe Osteologie der Österreichischen Gesellschaft für Rheumatologie und Rehabilitation—ÖGR. Prophylaxis and therapy of the glucocorticoid-induced osteoporosis—a review of recent guideline. Wien Klin Wochenschr. 2011;123(21–22):633–44. doi:10.1007/s00508-011-0042-8. Epub 2011 Aug 25.

    Article  CAS  PubMed  Google Scholar 

  26. Woolf AD. An update on glucocorticoid-induced osteoporosis. Curr Opin Rheumatol. 2007;19(4):370–5.

    CAS  PubMed  Google Scholar 

  27. Cimmino MA, Salvarani C, Macchioni P, Gerli R, Bartoloni Bocci E, Montecucco C, Caporali R, Systemic Vasculitis Study Group of the Italian Society for Rheumatology. Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids. Clin Exp Rheumatol. 2008;26(3):395–400.

    CAS  PubMed  Google Scholar 

  28. Svoboda T, Andel I, Burgschmidt I, et al. A corticosteroid side effect questionnaire discriminates between corticosteroid using and not-using patients with rheumatoid arthritis (RA) and polymyalgia rheumatica (PMR). Ann Rheum Dis. 2004;Suppl I:174 (THU 0221); EULAR 2004, Berlin.

    Google Scholar 

  29. Narváez J, Narváez JA, Nolla JM, Sirvent E, Reina D, Valverde J. Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. Rheumatology (Oxford). 2005;44(4):479–83.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 2nd Department of Medicine, Center for Rheumatology, Lower Austria, Austria

    Burkhard F. Leeb

  2. Karl Landsteiner Institute for Clinical Rheumatology, State Hospital Stockerau, Stockerau, Austria

    Burkhard F. Leeb

Authors
  1. Burkhard F. Leeb
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Burkhard F. Leeb .

Editor information

Editors and Affiliations

  1. Department of Rheumatology, National Institute of Rheumatic Diseases, Piešťany, Slovakia

    Jozef Rovenský

  2. 2nd Department of Medicine, State Hospital of Stockerau, Stockerau, Austria

    Burkhard Leeb

  3. 2nd Internal Clinic Medical Faculty, Comenius University, Bratislava, Slovakia

    Viera Štvrtinová

  4. Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia

    Richard Imrich

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Leeb, B.F. (2017). Monitoring Tools for Polymyalgia Rheumatica/Giant Cell Arteritis. In: Rovenský, J., Leeb, B., Štvrtinová, V., Imrich, R. (eds) Polymyalgia Rheumatica and Giant Cell Arteritis. Springer, Cham. https://doi.org/10.1007/978-3-319-52222-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-52222-7_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-52221-0

  • Online ISBN: 978-3-319-52222-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation